Polymorphisms of miRNA genes and in the 3'UTR region of the ADME genes in breast cancer patients treated with FAC (5-fluorouracil, doxorubicyn, cyclophosphamide) chemotherapy.
2016/21/D/NZ5/01913
Keywords
Descriptors
- NZ5_1: Etiologia chorób człowieka
- NZ5_7: Leczenie chorób człowieka
- NZ5_9: Inne zagadnienia pokrewne
Panel
NZ5 – Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution
Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie
Voivodeship: mazowieckie
Principal investigator (from the host institution)
Number of co-investigators in the project: 3
Call
SONATA 11 – announced on 2016-03-15
- Amount awarded
- 452 300 PLN
- Project start date
- 2017-02-23
- Project end date
- 2021-10-22
- Project duration
- 56 months (the same as in the proposal)
- Project status
- Project settled
Project description
Download the project description in a pdf file
Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
Publication in academic press/journals (1)
-
Genetic 3′UTR variations and clinical factors significantly contribute to survival prediction and clinical response in breast cancer patients
- Authors:
- Jolanta Pamuła-Piłat, Karolina Tęcza, Magdalena Kalinowska-Herok, Ewa Grzybowska
- Academic press:
- Scientific Reports (year: 2020, volume: 10, pages: -), Publisher: Nature Research
- Status:
- Published
- DOI:
- 10.1038/s41598-020-62662-z – link to the publication